InvestorsHub Logo
Followers 1
Posts 285
Boards Moderated 0
Alias Born 02/10/2021

Re: Vanasn post# 37715

Thursday, 03/10/2022 9:13:03 PM

Thursday, March 10, 2022 9:13:03 PM

Post# of 44274
They weren't supposed to make that deal, it is a terrible deal period.

They won't be able to pay it off becasue they haven't even entered clinical trials, and those take a long time and after that they have to get appproval of the drugs etc. there is no way they can do that within a year.

They simply won't generate revenue and therefore this will get diluted into trips.

I have called 2-3 cents share price in march and we have alrdy been there today and now I am calling trips within this year, watch.

Now we know why they approved R/S... they are gonna dilute this POS, RS and do it all over again

trips unless miracle happens.